Chronic Kidney Disease (CKD) Stage 5
Conditions
Brief summary
Peritoneal dialysis is an effective renal replacement therapy with higher quality of life and lower treatment cost than hemodialysis.However, the application rate of peritoneal dialysis is much lower than that of hemodialysis. One of the reasons is that patients need to complete fluid changing operation independently, which is especially challenging for elderly and frail patients. Assisted peritoneal dialysis can help patients with independent dialysis disorders to complete dialysis. Currently, there is a lack of standard tools to assess patients' ability to conduct independent dialysis and to determine whether assisted dialysis is needed. Moreover, routine assessment is arranged after the training of dialysis operation, which leads to some patients giving up the procedure at an early stage, resulting in a low selection rate of the procedure.The purpose of this study was to investigate the effect of using a standard scale to evaluate the ability to perform abdominal dialysis in patients with stage 5 chronic kidney disease (CKD) before deciding on dialysis modality.
Interventions
OTHERSelf-care PD ability assessment form
Subjects will be evaluated using the self-care PD feasibility assessment tool within 7 days after randomization. The evaluation results will be provided to the patient on the same day
OTHEREducation
Education on renal replacement therapy and dialysis
Sponsors
Shanghai Jiao Tong University School of Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age \>=18 years old; 2. Need dialysis within 6 months; 3. Informed consent.
Exclusion criteria
1. Absolute PD contraindications; 2. Need urgent dialysis; 3. RTX as initial renal replacement therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of PD choice | up to 90 days |
Secondary
| Measure | Time frame |
|---|---|
| The aPD utilization rate | up to 180 days |
Countries
China
Contacts
Primary ContactNa Jiang, MD
Outcome results
None listed